Literature DB >> 20820191

iPSC lines that do not silence the expression of the ectopic reprogramming factors may display enhanced propensity to genomic instability.

Veronica Ramos-Mejia1, Martin Muñoz-Lopez, Jose L Garcia-Perez, Pablo Menendez.   

Abstract

Here, we provide data suggesting that the absence of silencing of the ectopic reprogramming factors used to reprogram somatic cells to induced pluripotent stem cells (iPSCs) may predispose iPSCs to genomic instability. We encourage stem cell scientists to undertake an extensive characterization and standardization of much larger cohorts of iPSC lines in order to set up rigorous criteria to define safe and stable bona fide iPSCs.

Mesh:

Year:  2010        PMID: 20820191     DOI: 10.1038/cr.2010.125

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  17 in total

1.  Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα.

Authors:  C Bueno; J L Sardina; B Di Stefano; D Romero-Moya; A Muñoz-López; L Ariza; M C Chillón; A Balanzategui; J Castaño; A Herreros; M F Fraga; A Fernández; I Granada; O Quintana-Bustamante; J C Segovia; K Nishimura; M Ohtaka; M Nakanishi; T Graf; P Menendez
Journal:  Leukemia       Date:  2015-10-26       Impact factor: 11.528

Review 2.  The tumorigenicity of human embryonic and induced pluripotent stem cells.

Authors:  Uri Ben-David; Nissim Benvenisty
Journal:  Nat Rev Cancer       Date:  2011-03-10       Impact factor: 60.716

3.  Genetic instability of modified stem cells - a first step towards malignant transformation?

Authors:  Doris Steinemann; Gudrun Göhring; Brigitte Schlegelberger
Journal:  Am J Stem Cells       Date:  2013-03-08

Review 4.  Raising the standards of stem cell line quality.

Authors:  Michael P Yaffe; Scott A Noggle; Susan L Solomon
Journal:  Nat Cell Biol       Date:  2016-03       Impact factor: 28.824

Review 5.  Glial progenitor cell-based treatment of the childhood leukodystrophies.

Authors:  M Joana Osorio; Steven A Goldman
Journal:  Exp Neurol       Date:  2016-05-08       Impact factor: 5.330

Review 6.  Cellular reprogramming: a small molecule perspective.

Authors:  Baoming Nie; Haixia Wang; Timothy Laurent; Sheng Ding
Journal:  Curr Opin Cell Biol       Date:  2012-09-07       Impact factor: 8.382

Review 7.  Is Transforming Stem Cells to Pancreatic Beta Cells Still the Holy Grail for Type 2 Diabetes?

Authors:  Sevim Kahraman; Erin R Okawa; Rohit N Kulkarni
Journal:  Curr Diab Rep       Date:  2016-08       Impact factor: 4.810

8.  Human pluripotent stem cells: applications and challenges in neurological diseases.

Authors:  Youssef Hibaoui; Anis Feki
Journal:  Front Physiol       Date:  2012-07-20       Impact factor: 4.566

9.  Transgene excision has no impact on in vivo integration of human iPS derived neural precursors.

Authors:  Tamara Major; Jayanthi Menon; Gordon Auyeung; Frank Soldner; Dirk Hockemeyer; Rudolf Jaenisch; Viviane Tabar
Journal:  PLoS One       Date:  2011-09-22       Impact factor: 3.240

10.  A promoter DNA demethylation landscape of human hematopoietic differentiation.

Authors:  Vincenzo Calvanese; Agustín F Fernández; Rocío G Urdinguio; Beatriz Suárez-Alvarez; Cristina Mangas; Vicente Pérez-García; Clara Bueno; Rosa Montes; Verónica Ramos-Mejía; Pablo Martínez-Camblor; Cecilia Ferrero; Yassen Assenov; Christoph Bock; Pablo Menendez; Ana Clara Carrera; Carlos Lopez-Larrea; Mario F Fraga
Journal:  Nucleic Acids Res       Date:  2011-09-12       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.